Gene · 10419
Papers3,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion-Defined Rhabdomyosarcoma. | Mol Cancer Ther | 2025 | 40621788 | PubTator, text mining | PubMed |
| A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. | Biochem Pharmacol | 2025 | 40619015 | PubTator, text mining | PubMed |
| Polyamines at the crossroad between cell metabolism and epigenetic regulation in acute leukemias. | Cell Death Discov | 2025 | 40603833 | PubTator, text mining | PubMed |
| RIPK1 senses S-adenosylmethionine scarcity to drive cell death and inflammation. | Cell Metab | 2025 | 40570842 | PubTator, text mining | PubMed |
| MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models. | Clin Cancer Res | 2025 | 40553452 | PubTator, text mining | PubMed |
| Circular RNA rising star: new findings of circPRMT5 in cancer. | Mol Biol Rep | 2025 | 40533708 | PubTator, text mining | PubMed |
| Dismantling the epigenetic alliance: Emerging strategies to disrupt the PRMT5:MEP50 complex for cancer therapy. | Eur J Med Chem | 2025 | 40532498 | PubTator, text mining | PubMed |
| Emerging roles of protein arginine methyltransferase in multiple myeloma. | Mol Ther Oncol | 2025 | 40524859 | PubTator, text mining | PubMed |
| A proximity-induced chimera platform for targeted protein arginine methylation. | Acta Pharm Sin B | 2025 | 40487645 | PubTator, text mining | PubMed |
| PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer. | Cell Signal | 2025 | 40484103 | PubTator, text mining | PubMed |
| MicroRNA-100-5p Exacerbates Myocardial Ischemia-Reperfusion Injury Through Downregulation of PRMT5. | FASEB J | 2025 | 40471103 | PubTator, text mining | PubMed |
| Identification of a Selective Cell-Active Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) for the Treatment of Prostate Cancer by Structure-Based Virtual Screening. | Chem Biol Drug Des | 2025 | 40468526 | PubTator, text mining | PubMed |
| A 3D generation framework using diffusion model and reinforcement learning to generate multi-target compounds with desired properties. | J Cheminform | 2025 | 40468393 | PubTator, text mining | PubMed |
| Combined inhibition by PRMT5 and MAT2A demonstrates a strong synthetic lethality in MTAP homozygous-deficient glioma models. | Cell Death Discov | 2025 | 40450009 | PubTator, text mining | PubMed |
| Epigenetically targeting PRMT5 promotes antitumor immunity by inducing endogenous retroviruses expression and triggering viral mimicry response. | Transl Res | 2025 | 40449620 | PubTator, text mining | PubMed |
| Evolutionary interplay between viruses and R-loops. | FEBS Lett | 2025 | 40448548 | PubTator, text mining | PubMed |
| PRMT5 K240lac confers ferroptosis resistance via ALKBH5/SLC7A11 axis in colorectal cancer. | Oncogene | 2025 | 40447754 | PubTator, text mining | PubMed |
| Discovery and Mechanism of 16-19F, a Novel Synthetic Lethal Inhibitor of the PRMT5•MTA Complex in MTAP-Deleted Cancer Cells. | ACS Chem Biol | 2025 | 40440106 | PubTator, text mining | PubMed |
| Drug discovery targeting protein arginine methyltransferase 5 (PRMT5): an update. | Bioorg Med Chem | 2025 | 40412016 | PubTator, text mining | PubMed |
| Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy. | Discov Oncol | 2025 | 40399547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10419/papers?page=15